Denise, Jack, Magda, Winnie, Kathy and Kathy Thank you so much for sending your opinions, thoughts and information. Yes, this is an HIV-transmission study, looking at the effect of nevirapine on mother-to-child transmission. I believe that the nevirapine will be discontinued at 24 weeks, which means that the babies will no longer be protected against of the virus in the breastmilk after that time. I have not seen the protocol, but I would speculate that, since this is the case, the mothers are invited to choose about whether to continue breastfeeding or not. I am told that the study is being funded and overseen by a large US organization and much, much larger numbers of babies from Uganda, Kenya, South Africa and Zimbabwe will be included in the next phase of the research if this one goes as expected. This is the seventh and eighth study involving replacement feeding (all organized by US-based or Australian organizations) that I have heard about in this country in the last couple of years. If anyone else wants to comment on the above, or to send more thoughts on what is the "best" replacement feed, I'm listening! Thanks again. Comments so far have been very, very helpful. Pamela Morrison IBCLC, Zimbabwe [log in to unmask] *********************************************** The LACTNET mailing list is powered by L-Soft's renowned LISTSERV(R) list management software together with L-Soft's LSMTP(TM) mailer for lightning fast mail delivery. For more information, go to: http://www.lsoft.com/LISTSERV-powered.html